|
|
|
|
| LEADER |
02839nam a2200697 4500 |
| 001 |
ocn893202845 |
| 003 |
OCoLC |
| 005 |
20170124071702.2 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
141015s2015 nju ob 001 0 eng |
| 010 |
|
|
|a 2014040927
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d N$T
|d IDEBK
|d DG1
|d RECBK
|d STF
|d COO
|d CDX
|d E7B
|d YDXCP
|d MMU
|d OCLCF
|d OCLCQ
|d DEBBG
|d EBLCP
|d K6U
|d GrThAP
|
| 019 |
|
|
|a 961632602
|a 962630457
|
| 020 |
|
|
|a 9781118995280
|q (Adobe PDF)
|
| 020 |
|
|
|a 1118995287
|q (Adobe PDF)
|
| 020 |
|
|
|a 9781118996416
|q (ePub)
|
| 020 |
|
|
|a 1118996410
|q (ePub)
|
| 020 |
|
|
|a 9781118995303
|
| 020 |
|
|
|a 1118995309
|
| 020 |
|
|
|a 9781322950167
|
| 020 |
|
|
|a 1322950164
|
| 020 |
|
|
|z 9780470317617
|q (hardback)
|
| 020 |
|
|
|z 0470317612
|q (hardback)
|
| 029 |
1 |
|
|a CHBIS
|b 010442421
|
| 029 |
1 |
|
|a CHVBK
|b 334093848
|
| 029 |
1 |
|
|a DEBBG
|b BV042793948
|
| 029 |
1 |
|
|a GBVCP
|b 819918644
|
| 029 |
1 |
|
|a DEBBG
|b BV043397209
|
| 035 |
|
|
|a (OCoLC)893202845
|z (OCoLC)961632602
|z (OCoLC)962630457
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RM301.25
|
| 060 |
|
4 |
|a QU 68
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 615.1/9
|2 23
|
| 049 |
|
|
|a MAIN
|
| 245 |
0 |
0 |
|a Peptide chemistry and drug design /
|c edited by Ben M. Dunn.
|
| 264 |
|
1 |
|a Hoboken, New Jersey :
|b Wiley,
|c 2015.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 520 |
|
|
|a "This book details many of the problems and successes of peptides as potential drugs"--Provided by publisher.
|
| 588 |
0 |
|
|a Print version record and CIP data provided by publisher.
|
| 505 |
0 |
|
|a Peptide therapeutics -- Methods for the peptide synthesis and analysis -- Peptide design strategies for g-protein coupled receptors (GPCRs) -- Peptide-based inhibitors of enzymes -- Discovery of peptide drugs as enzyme inhibitors and activators -- Discovery of peptide drugs from natural sources -- Modification of peptides to limit metabolism -- Delivery of peptide drugs.
|
| 650 |
|
0 |
|a Drugs
|x Design.
|
| 650 |
|
0 |
|a Peptide drugs.
|
| 650 |
|
0 |
|a Peptides
|x Synthesis.
|
| 650 |
|
2 |
|a Peptides
|x chemistry.
|
| 650 |
|
2 |
|a Drug Design.
|
| 650 |
|
2 |
|a Pharmaceutical Preparations.
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Drugs
|x Design.
|2 fast
|0 (OCoLC)fst00898790
|
| 650 |
|
7 |
|a Peptide drugs.
|2 fast
|0 (OCoLC)fst01057556
|
| 650 |
|
7 |
|a Peptides
|x Synthesis.
|2 fast
|0 (OCoLC)fst01057580
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Dunn, Ben M.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Peptide chemistry and drug design.
|d Hoboken, New Jersey : Wiley, 2015
|z 9780470317617
|w (DLC) 2014040280
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9781118995303
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|
